EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+22.83%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$3.61B
AUM Growth
+$682M
(+23%)
Cap. Flow
+$165M
Cap. Flow
% of AUM
4.58%
Top 10 Holdings %
Top 10 Hldgs %
17.47%
Holding
954
New
83
Increased
179
Reduced
131
Closed
34
Top Buys
| 1 |
Biogen
BIIB
|
+$35.3M |
| 2 |
Signet Jewelers
SIG
|
+$13.5M |
| 3 |
Microsoft
MSFT
|
+$12.7M |
| 4 |
Silicon Motion
SIMO
|
+$11M |
| 5 |
TJX Companies
TJX
|
+$11M |
Top Sells
| 1 |
Darden Restaurants
DRI
|
+$27.2M |
| 2 |
Tapestry
TPR
|
+$15.7M |
| 3 |
Ameriprise Financial
AMP
|
+$12.6M |
| 4 |
Abbott
ABT
|
+$9.4M |
| 5 |
Denali Therapeutics
DNLI
|
+$9.37M |
Sector Composition
| 1 | Technology | 27.61% |
| 2 | Healthcare | 21.59% |
| 3 | Consumer Discretionary | 15.04% |
| 4 | Industrials | 8.92% |
| 5 | Financials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
226
DELISTED
Sage Therapeutics
SAGE
| $2.92M | 0.08% |
33,500
+14,800
| +79% | +$1.29M |
|
|
MRTX
227
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.92M | 0.08% |
13,200
-100
| -0.8% | -$22.1K |
|
228
Arrowhead Research
ARWR
$3.76B
| $2.91M | 0.08% |
+37,300
| New | +$2.91M |
|
|
WBA
229
DELISTED
Walgreens Boots Alliance
WBA
| $2.88M | 0.08% |
73,000
+15,000
| +26% | +$591K |
|
|
ZGNX
230
DELISTED
Zogenix, Inc.
ZGNX
| $2.86M | 0.08% |
144,900
+15,000
| +12% | +$296K |
|
231
Voyager Therapeutics
VYGR
$236M
| $2.82M | 0.08% |
387,900
+45,000
| +13% | +$327K |
|
232
Oneok
OKE
$45.2B
| $2.78M | 0.08% |
73,000
+62,200
| +576% | +$2.37M |
|
233
NetEase
NTES
$91.1B
| $2.71M | 0.08% |
29,000
| – | – |
|
234
PTC Therapeutics
PTCT
$4.52B
| $2.65M | 0.07% |
41,800
-16,000
| -28% | -$1.02M |
|
235
Elevance Health
ELV
$69.4B
| $2.6M | 0.07% |
8,273
+793
| +11% | +$249K |
|
|
236
Denali Therapeutics
DNLI
$2.25B
| $2.57M | 0.07% |
30,600
-111,600
| -78% | -$9.37M |
|
237
Ultragenyx Pharmaceutical
RARE
$3.04B
| $2.54M | 0.07% |
17,210
-1,200
| -7% | -$177K |
|
238
iShares MSCI Canada ETF
EWC
$3.24B
| $2.52M | 0.07% |
81,160
+7,700
| +10% | +$239K |
|
239
Western Digital
WDC
$32.8B
| $2.42M | 0.07% |
66,339
+13,230
| +25% | +$483K |
|
|
GBT
240
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.36M | 0.07% |
53,500
| – | – |
|
241
iShares MSCI Pacific ex Japan ETF
EPP
$1.83B
| $2.35M | 0.07% |
48,910
+11,000
| +29% | +$529K |
|
242
Neurocrine Biosciences
NBIX
$14.3B
| $2.34M | 0.06% |
24,900
-14,800
| -37% | -$1.39M |
|
|
GWPH
243
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.33M | 0.06% |
20,300
-1,800
| -8% | -$207K |
|
244
Ascendis Pharma
ASND
$12.4B
| $2.33M | 0.06% |
+14,000
| New | +$2.33M |
|
|
RETA
245
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.3M | 0.06% |
17,700
-4,900
| -22% | -$636K |
|
246
Halozyme
HALO
$8.87B
| $2.27M | 0.06% |
53,700
-24,200
| -31% | -$1.02M |
|
|
TPTX
247
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $2.25M | 0.06% |
18,700
-4,800
| -20% | -$577K |
|
248
Ormat Technologies
ORA
$5.48B
| $2.23M | 0.06% |
24,720
+15,650
| +173% | +$1.41M |
|
249
Whirlpool
WHR
$5.24B
| $2.21M | 0.06% |
+12,050
| New | +$2.21M |
|
250
Marsh & McLennan
MMC
$99.2B
| $2.19M | 0.06% |
19,100
+2,100
| +12% | +$241K |
|